Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acoustic impedance mismatch in intravascular ultrasound refers to the physical phenomenon where differences in acoustic impedance between adjacent media (e.g., blood and vessel wall, or vessel wall and plaque) cause partial reflection and transmission of ultrasound waves at interfaces[7]. This mismatch leads to enhancement or attenuation of ultrasound signals, depending on the degree of impedance difference. In cardiovascular ultrasound, such mismatches may create artifacts in Doppler spectral measurements and affect image accuracy, especially post-stenosis in coronary arteries. The concept is a physical property of materials/tissues, not a molecular or therapeutic target. Devices such as ultrasound transducers may use specially designed matching layers (e.g., cone-structured metamaterials) to minimize these effects and optimize signal transmission, but the impedance mismatch itself is not a druggable or biologically regulated entity[1][3][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acoustic impedance mismatch (intravascular ultrasound context).